Is Zai Lab Ltd (ZLAB) overvalued? · rev $399.0M
Zai Lab Ltd (ZLAB) is a biotechnology company listed on NASDAQ.
This page asks whether Zai Lab Ltd (ZLAB) looks expensive on cached numbers — not a short thesis.
Latest reported ZLAB revenue for 2024-12-31 was $399.0M. Net income was -$257.1M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. ZLAB currently screens at market cap $2.02B.
ZLAB currently screens at market cap $2.02B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ZLAB 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ZLAB stock page for the full model, not this heading.
Not investment advice.